Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Cardiology
•
Interventional Cardiology
What has been your experience with Coronary CTA with FFR results and its ability to accurately predict epicardial CAD on diagnostic LHC?
Related Questions
Do you recommend routine use of protamine for hemostasis at the end of a transfemoral TAVI?
How would you proceed with V-A ECMO cannulation (Venous cannula) on a patient with massive PE who has an IVC filter with high thrombus burden?
Would you recommend normal saline for pre- and post-LHC hydration in patients with CKD stage III to IV with reduced LV systolic function, and if so, what is a reasonable amount of volume?
How soon after an elective, uncomplicated coronary intervention would you feel comfortable having a patient travel by air?
For SVG graft stenting, do you consider routinely embolic protection devices (EPD), and do you factor lesion location (prox vs distal) for decision making?
Do shorter door-to-balloon (D2B) times impact outcomes in STEMI, if it's already less than 90 minutes, and to what degree (i.e., 30 vs 60 minutes would have a more significant impact)?
What is/are your preferred technique(s) for obtaining LV-Ao pressure gradients in the cath lab?
What techniques do you use in the lab to reduce the amount of contrast that needs to be used in patients with CKD?
How do you decide between manual pressure versus opting for a specific vascular closure device at the conclusion of a femoral access case?
What has been your approach to minimizing the risk of vascular complications when placing Impella support devices?
